Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,261.15 INR | +0.82% |
|
-1.77% | -9.16% |
Capitalization | 1,049B 12.2B 10.51B 9.78B 9.11B 16.75B 18.73B 118B 44.82B 491B 45.77B 44.83B 1,817B | P/E ratio 2026 * |
18.1x | P/E ratio 2027 * | 21.7x |
---|---|---|---|---|---|
Enterprise value | 1,005B 11.69B 10.07B 9.37B 8.73B 16.04B 17.94B 114B 42.93B 470B 43.84B 42.94B 1,740B | EV / Sales 2026 * |
2.85x | EV / Sales 2027 * | 2.79x |
Free-Float |
70.34% | Yield 2026 * |
0.81% | Yield 2027 * | 0.85% |
More valuation ratios
* Estimated data
More news
Last Transcript: Dr. Reddy's Laboratories Limited
More recommendations
Dr Reddy Laboratories : Stock Exchange intimation dated 15072025 | Jul. 15 | PU |
Dr Reddy Laboratories : DRL IR 2025 DMA v5 140725 | Jul. 15 | PU |
Dr Reddy Laboratories : ESOP annexure FY 2025 | Jul. 14 | PU |
Dr Reddy Laboratories : FTO2 ISO-14001 | Jul. 14 | PU |
Dr Reddy Laboratories : FTO2 ISO-45001 | Jul. 14 | PU |
More news
1 day | +0.82% | ||
1 week | -1.77% | ||
Current month | -1.76% | ||
1 month | -7.37% | ||
3 months | +9.11% | ||
6 months | -5.83% | ||
Current year | -9.16% |
1 week | 1,241.4 | ![]() | 1,272.1 |
1 month | 1,212.35 | ![]() | 1,353 |
Current year | 1,025.9 | ![]() | 1,404.6 |
1 year | 1,025.9 | ![]() | 1,420.2 |
3 years | 799.22 | ![]() | 1,420.2 |
5 years | 731 | ![]() | 1,420.2 |
10 years | 377.6 | ![]() | 1,420.2 |
Manager | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 58 | 2019-06-30 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 2023-07-31 |
K. Randhir Singh
CMP | Compliance Officer | - | 2022-03-16 |
Director | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 2014-05-12 | |
Gunupati Prasad
CHM | Chairman | 64 | 2013-04-01 |
Leo Puri
BRD | Director/Board Member | 64 | 2018-10-24 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.82% | -1.77% | -7.17% | +38.81% | 12.1B | ||
-3.45% | -0.76% | -18.80% | +132.74% | 718B | ||
-1.05% | -0.40% | +3.97% | -12.94% | 377B | ||
-1.84% | -1.78% | +10.93% | +21.33% | 338B | ||
-2.29% | -3.74% | -55.50% | +3.48% | 308B | ||
-1.05% | -1.05% | -1.43% | -23.16% | 259B | ||
-0.38% | -1.69% | -3.07% | +16.27% | 237B | ||
-1.56% | +1.51% | -13.28% | -5.53% | 222B | ||
-2.57% | +0.18% | -36.37% | -14.15% | 210B | ||
-1.52% | -1.51% | -11.40% | +17.62% | 160B | ||
Average | -0.74% | -0.35% | -13.21% | +17.45% | 284.21B | |
Weighted average by Cap. | -0.75% | -0.11% | -13.72% | +33.63% |
2026 * | 2027 * | |
---|---|---|
Net sales | 353B 4.11B 3.54B 3.29B 3.07B 5.64B 6.3B 39.88B 15.08B 165B 15.4B 15.09B 612B | 351B 4.08B 3.51B 3.27B 3.04B 5.59B 6.26B 39.58B 14.97B 164B 15.29B 14.97B 607B |
Net income | 58.44B 680M 585M 545M 507M 933M 1.04B 6.6B 2.5B 27.34B 2.55B 2.5B 101B | 48.64B 566M 487M 453M 422M 776M 868M 5.49B 2.08B 22.75B 2.12B 2.08B 84.21B |
Net Debt | -44.24B -514M -443M -412M -384M -706M -790M -5B -1.89B -20.69B -1.93B -1.89B -76.59B | -70.73B -823M -708M -659M -614M -1.13B -1.26B -7.99B -3.02B -33.09B -3.09B -3.02B -122B |
More financial data
* Estimated data
Employees
27,811
Sector
Pharmaceuticals
Calendar
Jul. 22
- Q1 2026 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-15 | 1,261.15 ₹ | +0.82% | 13,083 |
25-07-14 | 1,250.95 ₹ | -0.24% | 10,372 |
25-07-11 | 1,254.00 ₹ | -0.41% | 214,602 |
25-07-10 | 1,259.20 ₹ | -0.82% | 51,480 |
25-07-09 | 1,269.55 ₹ | -1.12% | 74,082 |
Delayed Quote Bombay S.E., July 15, 2025 at 06:00 am EDT
More quotesSell
Buy

Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,261.15INR
Average target price
1,262.39INR
Spread / Average Target
+0.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DRREDDY Stock
Select your edition
All financial news and data tailored to specific country editions